Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283

Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on ashitaba sap as a novel food (NF) pursuant to Regulation (EU) 2015/2283. Ashitaba sap is collected from harvested stems of Angelica keiskei...

Full description

Saved in:
Bibliographic Details
Main Authors: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, Alexandre Maciuk, Inge Mangelsdorf, Harry J. McArdle, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Margarita Aguilera‐Gómez, Francesco Cubadda, Thomas Frenzel, Marina Heinonen, Miguel Prieto Maradona, Monika Neuhäuser‐Berthold, Morten Poulsen, Josef Rudolf Schlatter, Alexandros Siskos, Henk vanLoveren, Maria Glymenaki, Eirini Kouloura, Helle Katrine Knutsen
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:EFSA Journal
Subjects:
Online Access:https://doi.org/10.2903/j.efsa.2024.8645
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061547995398144
author EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)
Dominique Turck
Torsten Bohn
Jacqueline Castenmiller
Stefaan De Henauw
Karen Ildico Hirsch‐Ernst
Alexandre Maciuk
Inge Mangelsdorf
Harry J. McArdle
Androniki Naska
Kristina Pentieva
Alfonso Siani
Frank Thies
Sophia Tsabouri
Marco Vinceti
Margarita Aguilera‐Gómez
Francesco Cubadda
Thomas Frenzel
Marina Heinonen
Miguel Prieto Maradona
Monika Neuhäuser‐Berthold
Morten Poulsen
Josef Rudolf Schlatter
Alexandros Siskos
Henk vanLoveren
Maria Glymenaki
Eirini Kouloura
Helle Katrine Knutsen
author_facet EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)
Dominique Turck
Torsten Bohn
Jacqueline Castenmiller
Stefaan De Henauw
Karen Ildico Hirsch‐Ernst
Alexandre Maciuk
Inge Mangelsdorf
Harry J. McArdle
Androniki Naska
Kristina Pentieva
Alfonso Siani
Frank Thies
Sophia Tsabouri
Marco Vinceti
Margarita Aguilera‐Gómez
Francesco Cubadda
Thomas Frenzel
Marina Heinonen
Miguel Prieto Maradona
Monika Neuhäuser‐Berthold
Morten Poulsen
Josef Rudolf Schlatter
Alexandros Siskos
Henk vanLoveren
Maria Glymenaki
Eirini Kouloura
Helle Katrine Knutsen
author_sort EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)
collection DOAJ
description Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on ashitaba sap as a novel food (NF) pursuant to Regulation (EU) 2015/2283. Ashitaba sap is collected from harvested stems of Angelica keiskei plants. The principal constituents of the sap with regard to the safety assessment are chalcones (1%–2.25%) and furanocoumarins (< 0.01%). The applicant proposed to use the NF in food supplements at a maximum dose of 780 mg per day. The target population is adults excluding pregnant and lactating women. Taking into consideration the composition of the NF and the proposed uses, the composition of the NF is not nutritionally disadvantageous. There are no concerns regarding genotoxicity of the NF. Based on a 90‐day oral toxicity study performed with the product as intended to be placed on the market (30% ashitaba sap powder and 70% cyclodextrins), the Panel establishes a safe dose of 0.5 mg/kg body weight (bw) per day for the product as it is intended to be placed on the market. For the target population, i.e. adults, this safe dose corresponds to 35 mg per day of the product as it is intended to be placed on the market and 137 mg per day of the NF, which is lower than the use level proposed by the applicant. The Panel concludes that the NF is safe for the target population at intake levels up to 137 mg per day.
format Article
id doaj-art-24abb373771a4949b3bd10fa7556bbdd
institution DOAJ
issn 1831-4732
language English
publishDate 2024-03-01
publisher Wiley
record_format Article
series EFSA Journal
spelling doaj-art-24abb373771a4949b3bd10fa7556bbdd2025-08-20T02:50:12ZengWileyEFSA Journal1831-47322024-03-01223n/an/a10.2903/j.efsa.2024.8645Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)Dominique TurckTorsten BohnJacqueline CastenmillerStefaan De HenauwKaren Ildico Hirsch‐ErnstAlexandre MaciukInge MangelsdorfHarry J. McArdleAndroniki NaskaKristina PentievaAlfonso SianiFrank ThiesSophia TsabouriMarco VincetiMargarita Aguilera‐GómezFrancesco CubaddaThomas FrenzelMarina HeinonenMiguel Prieto MaradonaMonika Neuhäuser‐BertholdMorten PoulsenJosef Rudolf SchlatterAlexandros SiskosHenk vanLoverenMaria GlymenakiEirini KoulouraHelle Katrine KnutsenAbstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on ashitaba sap as a novel food (NF) pursuant to Regulation (EU) 2015/2283. Ashitaba sap is collected from harvested stems of Angelica keiskei plants. The principal constituents of the sap with regard to the safety assessment are chalcones (1%–2.25%) and furanocoumarins (< 0.01%). The applicant proposed to use the NF in food supplements at a maximum dose of 780 mg per day. The target population is adults excluding pregnant and lactating women. Taking into consideration the composition of the NF and the proposed uses, the composition of the NF is not nutritionally disadvantageous. There are no concerns regarding genotoxicity of the NF. Based on a 90‐day oral toxicity study performed with the product as intended to be placed on the market (30% ashitaba sap powder and 70% cyclodextrins), the Panel establishes a safe dose of 0.5 mg/kg body weight (bw) per day for the product as it is intended to be placed on the market. For the target population, i.e. adults, this safe dose corresponds to 35 mg per day of the product as it is intended to be placed on the market and 137 mg per day of the NF, which is lower than the use level proposed by the applicant. The Panel concludes that the NF is safe for the target population at intake levels up to 137 mg per day.https://doi.org/10.2903/j.efsa.2024.8645Angelica keiskeiashitabafood supplementnovel foodssafety
spellingShingle EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)
Dominique Turck
Torsten Bohn
Jacqueline Castenmiller
Stefaan De Henauw
Karen Ildico Hirsch‐Ernst
Alexandre Maciuk
Inge Mangelsdorf
Harry J. McArdle
Androniki Naska
Kristina Pentieva
Alfonso Siani
Frank Thies
Sophia Tsabouri
Marco Vinceti
Margarita Aguilera‐Gómez
Francesco Cubadda
Thomas Frenzel
Marina Heinonen
Miguel Prieto Maradona
Monika Neuhäuser‐Berthold
Morten Poulsen
Josef Rudolf Schlatter
Alexandros Siskos
Henk vanLoveren
Maria Glymenaki
Eirini Kouloura
Helle Katrine Knutsen
Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal
Angelica keiskei
ashitaba
food supplement
novel foods
safety
title Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
title_full Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
title_fullStr Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
title_full_unstemmed Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
title_short Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
title_sort safety of ashitaba sap as a novel food pursuant to regulation eu 2015 2283
topic Angelica keiskei
ashitaba
food supplement
novel foods
safety
url https://doi.org/10.2903/j.efsa.2024.8645
work_keys_str_mv AT efsapanelonnutritionnovelfoodsandfoodallergensnda safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT dominiqueturck safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT torstenbohn safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT jacquelinecastenmiller safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT stefaandehenauw safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT karenildicohirschernst safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT alexandremaciuk safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT ingemangelsdorf safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT harryjmcardle safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT andronikinaska safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT kristinapentieva safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT alfonsosiani safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT frankthies safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT sophiatsabouri safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT marcovinceti safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT margaritaaguileragomez safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT francescocubadda safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT thomasfrenzel safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT marinaheinonen safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT miguelprietomaradona safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT monikaneuhauserberthold safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT mortenpoulsen safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT josefrudolfschlatter safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT alexandrossiskos safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT henkvanloveren safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT mariaglymenaki safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT eirinikouloura safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283
AT hellekatrineknutsen safetyofashitabasapasanovelfoodpursuanttoregulationeu20152283